{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:26:51Z","timestamp":1761056811089},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1067\/mjd.2002.119087","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T22:14:26Z","timestamp":1030227266000},"page":"611-616","source":"Crossref","is-referenced-by-count":29,"title":["Granulomatous and suppurative dermatitis at interferon alfa injection sites: Report of 2 cases"],"prefix":"10.1067","volume":"46","author":[{"given":"Scott","family":"Sanders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Busam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Tahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.119087_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0190-9622(95)91382-3","article-title":"Cutaneous reactions to recombinant cytokine therapy","volume":"33","author":"Asnis","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib2","first-page":"144","article-title":"Cutaneous side effects associated with interferon alpha therapy: a review","volume":"56","author":"Chang","year":"1995","journal-title":"Cutis"},{"key":"10.1067\/mjd.2002.119087_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002018-199410020-00003","article-title":"Clinical toxicity of interferons","volume":"10","author":"Vial","year":"1994","journal-title":"Drug Safety"},{"key":"10.1067\/mjd.2002.119087_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10428199809050944","article-title":"Pyoderma gangrenosum triggered by alpha 2b interferon in a patient with chronic granulocytic leukemia","volume":"30","author":"Montoto","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1067\/mjd.2002.119087_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0190-9622(97)70223-8","article-title":"Injection site vasculitis in a patient receiving interferon alfa for chronic hepatitis C","volume":"37","author":"Christian","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib6","first-page":"443","article-title":"Local cutaneous reaction induced by subcutaneous interleukin-2 and interferon alpha-2a immunotherapy following ABMT","volume":"11","author":"Klapholz","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1067\/mjd.2002.119087_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0536.1989.tb03127.x","article-title":"Allergy of delayed type of recombinant interferon alpha-2C","volume":"20","author":"Detmar","year":"1989","journal-title":"Contact Dermatitis"},{"key":"10.1067\/mjd.2002.119087_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-4362.1991.tb04230.x","article-title":"Cutaneous local necrosis following interferon injections","volume":"30","author":"Cnudde","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib9","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/0959-8049(96)00161-X","article-title":"Severe cutaneous reactions following interferon injections","volume":"32A","author":"Azagury","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1067\/mjd.2002.119087_bib10","first-page":"783","article-title":"Necrose cutanee locale apres injection d'interferon alpha","volume":"22","author":"Christian","year":"1993","journal-title":"Presse Med"},{"key":"10.1067\/mjd.2002.119087_bib11","first-page":"582","article-title":"Autoimmune phenomenon associated with cutaneous aseptic necrosis during interferon alpha treatment for chronic myelogenous leukemia","volume":"34","author":"Levesque","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ajh.2830440320","article-title":"Cutaneous necrosis caused by injection of alpha interferon in a patient with chronic myelogenous leukemia","volume":"44","author":"Oeda","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1067\/mjd.2002.119087_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archderm.1992.01680140150028","article-title":"Cutaneous ulcerations secondary to interferon alpha therapy in Kaposi's sarcoma","volume":"128","author":"Orlow","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-2008-1066618","article-title":"Aseptic skin necrosis after subcutaneous injection of alpha interferon","volume":"114","author":"Rasokat","year":"1989","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1067\/mjd.2002.119087_bib15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0248-8663(00)00221-6","article-title":"Cutaneous reactions or necrosis from interferon alpha: can interferon be reintroduced after healing? Six case reports","volume":"21","author":"Sparsa","year":"2000","journal-title":"Rev Med Interne"},{"key":"10.1067\/mjd.2002.119087_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0190-9622(96)90761-6","article-title":"Cutaneous ulcerations resulting from intramuscular injections of interferon alpha","volume":"35","author":"Konohana","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib17","first-page":"40","article-title":"Interferon therapy of C-type chronic hepatitis","volume":"17","author":"Mihara","year":"1993","journal-title":"Miyazakiikaishi"},{"key":"10.1067\/mjd.2002.119087_bib18","first-page":"129","article-title":"A case of chronic myelogenous leukemia developing cutaneous ulcers during interferon alpha therapy","volume":"58","author":"Nagai","year":"1993","journal-title":"Int J Hematol"},{"key":"10.1067\/mjd.2002.119087_bib19","first-page":"436","article-title":"A case of cutaneous ulcers after intramuscular injections of interferon alpha","volume":"104","author":"Akiyama","year":"1994","journal-title":"Jpn J Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib20","first-page":"1047","article-title":"Drug eruptions of interferon alpha in patients with C-type hepatitis","volume":"104","author":"Tone","year":"1994","journal-title":"Jpn J Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-8278(96)80085-7","article-title":"Cutaneous necrosis by subcutaneous injection of a-interferon in a patient with chronic type B hepatitis","volume":"25","author":"Kontochristopoulos","year":"1996","journal-title":"J Hepatol"},{"key":"10.1067\/mjd.2002.119087_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1040-0486(94)80001-4","article-title":"Cutaneous drug reactions","volume":"6","author":"Prussick","year":"1994","journal-title":"Curr Probl Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/jir.1998.18.823","article-title":"Local cutaneous necrotizing lesions associated with interferon injections","volume":"18","author":"Krainick","year":"1998","journal-title":"J Interferon Cytokine Res"},{"key":"10.1067\/mjd.2002.119087_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1572-0241.1998.00463.x","article-title":"Cutaneous necrosis associated with interferon alpha-2b","volume":"93","author":"Sickler","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1067\/mjd.2002.119087_bib25","first-page":"523","article-title":"Severe local cutaneous necrosis during treatment with interferon-alpha and ribavarin for chronic viral hepatitis C","volume":"21","author":"de Ledinghen","year":"1997","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1067\/mjd.2002.119087_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1468-3083.1999.tb00870.x","article-title":"Cutaneous ulcers due to interferon seem not to be related to dosage","volume":"13","author":"Virgili","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1067\/mjd.2002.119087_bib27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/120347549900300610","article-title":"Interferon-induced cutaneous necrosis","volume":"3","author":"Sasseville","year":"1999","journal-title":"J Cutan Med Surg"},{"key":"10.1067\/mjd.2002.119087_bib28","first-page":"570","article-title":"A case of skin ulceration after subcutaneous injection of IFN-alpha","volume":"37","author":"Okamoto","year":"1995","journal-title":"Skin Res"},{"key":"10.1067\/mjd.2002.119087_bib29","first-page":"563","article-title":"Local cutaneous necrosis following interferon-alpha injection","volume":"37","author":"Matsukura","year":"1995","journal-title":"Skin Res"},{"key":"10.1067\/mjd.2002.119087_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0733-8635(05)70020-6","article-title":"Interferons in dermatology: present-day standard","volume":"16","author":"Stadler","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2002.119087_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1023\/A:1015957022073","article-title":"Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application","volume":"5","author":"Supersaxo","year":"1988","journal-title":"Pharm Res"},{"key":"10.1067\/mjd.2002.119087_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0190-9622(96)90762-8","article-title":"Reply to Konohana","volume":"35","author":"Gaspari","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0190-9622(97)70170-1","article-title":"Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum","volume":"37","author":"Elgart","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib34","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1046\/j.1365-2133.1999.02687.x","article-title":"Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon-alpha treatment for chronic hepatitis C","volume":"140","author":"Eberlein-Konig","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib35","first-page":"79","article-title":"Inhibition of wound healing in mice by local interferon a\/b injection","volume":"74","author":"Stout","year":"1993","journal-title":"Int J Exp Pathol"},{"key":"10.1067\/mjd.2002.119087_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2133.1986.tb02817.x","article-title":"Effect of recombinant alpha A-interferon on DNA synthesis and differentiation of human keratinocytes","volume":"1","author":"Stadler","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1523-1747.ep12275353","article-title":"Effects of alpha and beta interferons on cultured human keratinocytes","volume":"85","author":"Yaar","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/jir.1995.15.235","article-title":"Normal mouse skin lymphocyte, Langerhans' cell and keratinocyte responses to intradermal injections of interferon-A and interferon-G","volume":"15","author":"Tong","year":"1995","journal-title":"J Interferon Cytokine Res"},{"key":"10.1067\/mjd.2002.119087_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00000441-199307000-00007","article-title":"Normal human skin lymphocytic and Langerhan's cell responses to intradermal interferon alpha-2B injections","volume":"306","author":"Tong","year":"1993","journal-title":"Am J Med Sci"},{"key":"10.1067\/mjd.2002.119087_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00375725","article-title":"Immunohistochemical evaluation of basal cell carcinoma during intralesional treatment with alpha-2 interferon","volume":"282","author":"Mozzanica","year":"1990","journal-title":"Arch Dermatol Res"},{"key":"10.1067\/mjd.2002.119087_bib41","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0190-9622(91)70111-E","article-title":"Intralesional interferon alpha-2B in the treatment of basal cell carcinoma","volume":"24","author":"Buechner","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib42","first-page":"5155","article-title":"Inhibition of angiogenesis by interferons: effects on tumor and lymphocyte-induced vascular responses","volume":"47","author":"Sidky","year":"1987","journal-title":"Cancer Res"},{"key":"10.1067\/mjd.2002.119087_bib43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jcb.240550403","article-title":"Modulation of bovine microvascular endothelial cell proteoloytic properties by inhibitors of angiogenesis","volume":"55","author":"Pepper","year":"1994","journal-title":"J Cell Biochem"},{"key":"10.1067\/mjd.2002.119087_bib44","first-page":"209","article-title":"Induction of apoptosis in human dermal microvascular endothelial cells and infantile hemangiomas by interferon-alpha","volume":"117","author":"Sgonc","year":"1998","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1067\/mjd.2002.119087_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000040874","article-title":"Interferon-induced vasospasm in chronic myelogenous leukemia","volume":"100","author":"Zeidman","year":"1998","journal-title":"Acta Hematol"},{"key":"10.1067\/mjd.2002.119087_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(93)90242-H","article-title":"Thrombosis and recombinant interferon alpha","volume":"95","author":"Durand","year":"1993","journal-title":"Am J Med"},{"key":"10.1067\/mjd.2002.119087_bib47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jnci\/81.7.497","article-title":"Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice","volume":"81","author":"Dvorak","year":"1989","journal-title":"J the Natl Cancer Inst"},{"key":"10.1067\/mjd.2002.119087_bib48","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1529-0131(199905)42:5<1051::AID-ANR26>3.0.CO;2-Q","article-title":"Interferon-a may exacerbate cryoglobulinemia-related ischemic manifestations","volume":"42","author":"Cid","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mjd.2002.119087_bib49","first-page":"353","article-title":"Cutaneous manifestations of nutritional deficiency states and gastrointestinal disease","author":"Magro","year":"1997"},{"key":"10.1067\/mjd.2002.119087_bib50","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/archderm.1996.03890320076012","article-title":"Metastatic Crohn's disease: report of 3 cases with special reference to histopathologic findings","volume":"132","author":"Hackzell-Bradley","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0560.2001.280206.x","article-title":"Giant cells in pyoderma gangrenosum","volume":"28","author":"Sanders","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2002.119087_bib52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0560.1986.tb00466.x","article-title":"Histopathologic and immunopathologic study of pyoderma gangrenosum","volume":"13","author":"Su","year":"1996","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2002.119087_bib53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2133.1972.tb07441.x","article-title":"Pyoderma gangrenosum with altered cellular immunity and dermonecrotic factor","volume":"87","author":"Delecluse","year":"1972","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2002.119087_bib54","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(89)91078-7","article-title":"Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction","volume":"2","author":"Wakefield","year":"1989","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.119087_bib55","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0016-5085(91)90779-K","article-title":"Granulomatous vasculitis in Crohn's disease","volume":"100","author":"Wakefield","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1067\/mjd.2002.119087_bib56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/jir.1994.14.235","article-title":"Interferon expression in Crohn's disease patients: increased interferon-gamma and alpha mRNA in the intestinal lamina propria mononuclear cells","volume":"14","author":"Fais","year":"1994","journal-title":"J Interferon Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202689765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202689765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T14:58:13Z","timestamp":1557413893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202689765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0190962202689765"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.119087","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}